This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ank, N. Articles by Paludan, S. R. Search for Related Content PubMed PubMed Citation Articles by Ank, N. Articles by Paludan, S. R.

 Previous Article  |  Next Article 

Journal of Virology, May 2006, p. 4501-4509, Vol. 80, No. 9
0022-538X/06/$08.00+0     doi:10.1128/JVI.80.9.4501-4509.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Lambda Interferon (IFN-), a Type III IFN, Is Induced by Viruses and IFNs and Displays Potent Antiviral Activity against Select Virus Infections In Vivo

Nina Ank,^1, Hans West,^1, Christina Bartholdy,² Kristina Eriksson,³ Allan R. Thomsen,² and Søren R. Paludan^1*

Institute of Medical Microbiology and Immunology, University of Aarhus, Aarhus, Denmark,¹ Institute of Medical Microbiology and Immunology, University of Copenhagen, Copenhagen, Denmark,² Department of Rheumatology and Inflammation Research, Göteborg University, Göteborg, Sweden³

Received 15 November 2005/ Accepted 16 February 2006

Type III interferons (IFNs) (interleukin-28/29 or lambda interferon [IFN-]) are cytokines with IFN-like activities. Here we show that several classes of viruses induce expression of IFN-1 and -2/3 in similar patterns. The IFN-s were—unlike alpha/beta interferon (IFN-/ß)—induced directly by stimulation with IFN- or -, thus identifying type III IFNs as IFN-stimulated genes. In vitro assays revealed that IFN-s have appreciable antiviral activity against encephalomyocarditis virus (EMCV) but limited activity against herpes simplex virus type 2 (HSV-2), whereas IFN- potently restricted both viruses. Using three murine models for generalized virus infections, we found that while recombinant IFN- reduced the viral load after infection with EMCV, lymphocytic choriomeningitis virus (LCMV), and HSV-2, treatment with recombinant IFN- in vivo did not affect viral load after infection with EMCV or LCMV but did reduce the hepatic viral titer of HSV-2. In a model for a localized HSV-2 infection, we further found that IFN- completely blocked virus replication in the vaginal mucosa and totally prevented development of disease, in contrast to IFN-, which had a more modest antiviral activity. Finally, pretreatment with IFN- enhanced the levels of IFN- in serum after HSV-2 infection. Thus, type III IFNs are expressed in response to most viruses and display potent antiviral activity in vivo against select viruses. The discrepancy between the observed antiviral activity in vitro and in vivo may suggest that IFN- exerts a significant portion of its antiviral activity in vivo via stimulation of the immune system rather than through induction of the antiviral state.

These two authors contributed equally to the work.

This article has been cited by other articles:

• Ank, N., Iversen, M. B., Bartholdy, C., Staeheli, P., Hartmann, R., Jensen, U. B., Dagnaes-Hansen, F., Thomsen, A. R., Chen, Z., Haugen, H., Klucher, K., Paludan, S. R. (2008). An Important Role for Type III Interferon (IFN-{lambda}/IL-28) in TLR-Induced Antiviral Activity. J. Immunol. 180: 2474-2485 [Abstract] [Full Text]  
• Wathelet, M. G., Orr, M., Frieman, M. B., Baric, R. S. (2007). Severe Acute Respiratory Syndrome Coronavirus Evades Antiviral Signaling: Role of nsp1 and Rational Design of an Attenuated Strain. J. Virol. 81: 11620-11633 [Abstract] [Full Text]  
• Osterlund, P. I., Pietila, T. E., Veckman, V., Kotenko, S. V., Julkunen, I. (2007). IFN Regulatory Factor Family Members Differentially Regulate the Expression of Type III IFN (IFN-{lambda}) Genes. J. Immunol. 179: 3434-3442 [Abstract] [Full Text]  
• Stoltz, M., Ahlm, C., Lundkvist, A., Klingstrom, J. (2007). Lambda Interferon (IFN-{lambda}) in Serum Is Decreased in Hantavirus-Infected Patients, and In Vitro-Established Infection Is Insensitive to Treatment with All IFNs and Inhibits IFN-{gamma}-Induced Nitric Oxide Production. J. Virol. 81: 8685-8691 [Abstract] [Full Text]  
• Zhou, Z., Hamming, O. J., Ank, N., Paludan, S. R., Nielsen, A. L., Hartmann, R. (2007). Type III Interferon (IFN) Induces a Type I IFN-Like Response in a Restricted Subset of Cells through Signaling Pathways Involving both the Jak-STAT Pathway and the Mitogen-Activated Protein Kinases. J. Virol. 81: 7749-7758 [Abstract] [Full Text]  
• Huang, J., Smirnov, S. V., Lewis-Antes, A., Balan, M., Li, W., Tang, S., Silke, G. V., Putz, M. M., Smith, G. L., Kotenko, S. V. (2007). Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc. Natl. Acad. Sci. USA 104: 9822-9827 [Abstract] [Full Text]  
• Onoguchi, K., Yoneyama, M., Takemura, A., Akira, S., Taniguchi, T., Namiki, H., Fujita, T. (2007). Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism. J. Biol. Chem. 282: 7576-7581 [Abstract] [Full Text]